976 related articles for article (PubMed ID: 20375205)
1. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.
Guan C; Zahid S; Minhas AS; Ouyang P; Vaught A; Baker VL; Michos ED
Fertil Steril; 2022 May; 117(5):924-935. PubMed ID: 35512976
[TBL] [Abstract][Full Text] [Related]
3. The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis.
Woodward A; Klonizakis M; Lahart I; Carter A; Dalton C; Metwally M; Broom D
Syst Rev; 2019 May; 8(1):116. PubMed ID: 31097035
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome: associations with cardiovascular disease.
Benham JL; Goldberg A; Teede H; Tay CT
Climacteric; 2024 Feb; 27(1):47-52. PubMed ID: 38073517
[TBL] [Abstract][Full Text] [Related]
5. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome.
Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS
Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic Risk in Polycystic Ovary Syndrome: Current Guidelines.
Cooney LG; Dokras A
Endocrinol Metab Clin North Am; 2021 Mar; 50(1):83-95. PubMed ID: 33518188
[TBL] [Abstract][Full Text] [Related]
7. Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
Dwivedi AK; Vishwakarma D; Dubey P; Reddy S
Eur J Endocrinol; 2023 Jun; 188(6):555-563. PubMed ID: 37307574
[TBL] [Abstract][Full Text] [Related]
8. Supervised exercise training and increased physical activity to reduce cardiovascular disease risk in women with polycystic ovary syndrome: study protocol for a randomized controlled feasibility trial.
Woodward A; Broom D; Dalton C; Metwally M; Klonizakis M
Trials; 2020 Jan; 21(1):101. PubMed ID: 31959233
[TBL] [Abstract][Full Text] [Related]
9. Subclinical cardiovascular disease and polycystic ovary syndrome.
Gomez JMD; VanHise K; Stachenfeld N; Chan JL; Merz NB; Shufelt C
Fertil Steril; 2022 May; 117(5):912-923. PubMed ID: 35512975
[TBL] [Abstract][Full Text] [Related]
10. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.
Krentz AJ; von Mühlen D; Barrett-Connor E
Menopause; 2007; 14(2):284-92. PubMed ID: 17245231
[TBL] [Abstract][Full Text] [Related]
11. Heart health in polycystic ovary syndrome: time to act on the data.
Dokras A
Fertil Steril; 2022 May; 117(5):885-886. PubMed ID: 35512972
[TBL] [Abstract][Full Text] [Related]
12. Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome.
Berbrier DE; Leone CA; Adler TE; Bender JR; Taylor HS; Stachenfeld NS; Usselman CW
J Appl Physiol (1985); 2023 Apr; 134(4):868-878. PubMed ID: 36861670
[TBL] [Abstract][Full Text] [Related]
13. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
Kazemi M; Kim JY; Parry SA; Azziz R; Lujan ME
Am J Obstet Gynecol; 2021 May; 224(5):428-444.e8. PubMed ID: 33316275
[TBL] [Abstract][Full Text] [Related]
14. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
Subramanian A; Anand A; Adderley NJ; Okoth K; Toulis KA; Gokhale K; Sainsbury C; O'Reilly MW; Arlt W; Nirantharakumar K
Eur J Endocrinol; 2021 May; 184(5):637-645. PubMed ID: 33635829
[TBL] [Abstract][Full Text] [Related]
15. Sleep disturbances, sleep quality, and cardiovascular risk factors in women with polycystic ovary syndrome: Systematic review and meta-analysis.
Zhang J; Ye J; Tao X; Lu W; Chen X; Liu C
Front Endocrinol (Lausanne); 2022; 13():971604. PubMed ID: 36176474
[TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic aspects of the polycystic ovary syndrome.
Randeva HS; Tan BK; Weickert MO; Lois K; Nestler JE; Sattar N; Lehnert H
Endocr Rev; 2012 Oct; 33(5):812-41. PubMed ID: 22829562
[TBL] [Abstract][Full Text] [Related]
17. Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study.
Mahboobifard F; Rahmati M; Niknam A; Rojhani E; Momenan AA; Azizi F; Ramezani Tehrani F
Arch Med Res; 2022 Apr; 53(3):312-322. PubMed ID: 34823887
[TBL] [Abstract][Full Text] [Related]
18. Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update.
Profili NI; Castelli R; Gidaro A; Manetti R; Maioli M; Petrillo M; Capobianco G; Delitala AP
J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337390
[TBL] [Abstract][Full Text] [Related]
19. Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study.
Ollila MM; Arffman RK; Korhonen E; Morin-Papunen L; Franks S; Junttila J; Piltonen TT
Eur J Endocrinol; 2023 Jul; 189(1):96-105. PubMed ID: 37436934
[TBL] [Abstract][Full Text] [Related]
20. Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome.
Pirotta S; Joham A; Grieger JA; Tay CT; Bahri-Khomami M; Lujan M; Lim SS; Moran LJ
Semin Reprod Med; 2020 Nov; 38(6):342-351. PubMed ID: 33873233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
